Lichtenstein, L., Koslowsky, B., Avni-Biron, I., Ovadia, B., Ben-Bassat, O., Naftali, T., Kopylov, U., Haberman, Y., Banai Eran, H., Eliakim, R., Lahat-Zok, A., Hirsch, A., Zittan, E., Maharshak, N., Waterman, M., Israeli, E., Goren, I., Ollech, J. E., Yanai, H., Ungar, B., Avidan, B., Ben Hur, D., Melamud, B., Segol, O., Shalem, Z., Dotan, I., Odes, S. H., Ben-Horin, S., Snir, Y., Milgrom, Y., Broide, E., Goldin, E., Delgado, S., Ron, Y., Cohen, N. A., Maoz, E., Zborovski, M., Odeh, S., Abu Freha, N., & Bar-Gil Shitrit, A. (n.d.). p275 Course of COVID-19 in patients with Inflammatory Bowel Diseases treated with biologics: the Israeli experience. Journal of Crohn's and colitis, 15, S307–S308. http://access.bl.uk/ark:/81055/vdc_100130765214.0x00000e